Completed PHASE3 INTERVENTIONAL 2-arm NCT00269386

Clarithromycin in Active Crohn's Disease

Randomised Controlled Trial of Clarithromycin in Active Crohn's Disease

Sponsor: Abbott

Updated 5 times since 2017 Last updated: Jan 6, 2009 Started: Apr 30, 2000 Primary completion: Dec 31, 2006 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Crohn's Disease, this trial is completed. The trial is conducted by Abbott and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Royal Liverpool University Hospital

Data source: Royal Liverpool University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liverpool, United Kingdom